|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/445 | |
| A61K 31/451 | |||
| A61P 29/00 |
| (11) | Number of the document | 2222299 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08852672.8 |
| Date of filing the European patent application | 2008-10-27 | |
| (97) | Date of publication of the European application | 2010-09-01 |
| (45) | Date of publication and mention of the grant of the patent | 2011-11-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/081328 |
| Date | 2008-10-27 |
| (87) | Number | WO 2009/067317 |
| Date | 2009-05-28 |
| (30) | Number | Date | Country code |
| 988913 P | 2007-11-19 | US |
| (72) |
BUCOLO, Claudio, IT
WARD, Keith, Wayne, US
ZHANG, Jinzhong, US
|
| (73) |
Bausch & Lomb Incorporated,
One Bausch & Lomb Place, Rochester, NY 14604-2701,
US
|
| (54) | USE OF LEVOCABASTINE FOR MODULATING GENERATION OF PRO-INFLAMMATORY CYTOKINES |
| USE OF LEVOCABASTINE FOR MODULATING GENERATION OF PRO-INFLAMMATORY CYTOKINES |